We studied the effect of focal cerebral isch emia on inducible (iNOS) and constitutive (cNOS) nitric oxide synthase enzymatic activities in the affected brain. The middle cerebral artery (MCA) was occluded in spon taneously hypertensive rats. Animals were killed 1, 2, 4, and 7 days later. cNOS and iNOS enzymatic activities were determined in the infarcted cortex using the assay of Bredt and Snyder. cNOS was assayed in the presence of calcium, whereas iNOS was assayed in the absence of calcium and in the presence of tetrahydrobiopterin. The validity of the iNOS assay was verified in rats treated with bacterial lipopolysaccharide. In these animals, the magnitude of the induction of iNOS enzymatic activity in lung, spleen, and brain paralleled the expression of iNOS mRNA, assessed by reverse-transcription polymerase chain reaction. After MCA occlusion, calcium-dependent (cNOS) activity was markedly reduced only in lesioned cerebral cortex at days 1-7 (p < 0.001; analysis of vari ance and Tukey's test). In contrast to cNOS, calcium-There is increasing evidence that mtnc oxide (NO) participates in the mechanisms of cerebral ischemia. However, the precise role that this agent plays in the pathogenesis of ischemic brain damage remains to be defined (Choi, 1993; Iadecola et aI., 
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We studied the effect of focal cerebral isch emia on inducible (iNOS) and constitutive (cNOS) nitric oxide synthase enzymatic activities in the affected brain. The middle cerebral artery (MCA) was occluded in spon taneously hypertensive rats. Animals were killed 1, 2, 4, and 7 days later. cNOS and iNOS enzymatic activities were determined in the infarcted cortex using the assay of Bredt and Snyder. cNOS was assayed in the presence of calcium, whereas iNOS was assayed in the absence of calcium and in the presence of tetrahydrobiopterin. The validity of the iNOS assay was verified in rats treated with bacterial lipopolysaccharide. In these animals, the magnitude of the induction of iNOS enzymatic activity in lung, spleen, and brain paralleled the expression of iNOS mRNA, assessed by reverse-transcription polymerase chain reaction. After MCA occlusion, calcium-dependent (cNOS) activity was markedly reduced only in lesioned cerebral cortex at days 1-7 (p < 0.001; analysis of vari ance and Tukey's test). In contrast to cNOS, calcium-There is increasing evidence that mtnc oxide (NO) participates in the mechanisms of cerebral ischemia. However, the precise role that this agent plays in the pathogenesis of ischemic brain damage remains to be defined (Choi, 1993; Iadecola et aI., independent (iN OS) activity was induced substantially in the infarct (p < 0.005) but not in the contralateral intact cortex (p > 0.05). iNOS activity peaked at day 2 and was not different from baseline at day 7 (p > 0.05). No NADPH diaphorase-positive neurons were observed in the area of the lesion at days 1-7. Macrophages appeared at day 2 and invaded the infarcted tissue by day 7. At this time, numerous glial fibrillary acidic protein-positive as trocytes were observed within the lesion. The results sug gest that the decline in calcium-dependent (cNOS) activ ity reflects loss of NOS neurons within the lesion. The induction of calcium-independent activity is likely to re flect induction of iNOS in non neuronal cells. Sustained nitric oxide production by iNOS may contribute to the late phase of tissue damage in focal cerebral ischemia. Key Words: Constitutive nitric oxide synthase (cNOS} Inducible NOS-Lipopolysaccharide antigen-Middle cerebral artery-Reverse-transcription polymerase chain reaction-Spontaneously hypertensive rats. 1994a). NO is synthesized by NO synthase (NOS), an enzyme for which several isoforms have been identified (for a review see Marietta, 1993) . Two distinct constitutive calcium-dependent NO syn thases (cNOS) are expressed, one in some neurons (Bredt et aI., 1990) and the other in endothelial cells (Lamas et aI., 1992) . A calcium-independent induc ible isoform (iN OS) can be induced in a wide vari ety of cells, most notably macrophages, glia, and vascular cells, by exposure to endotoxins or cyto kines (Stuehr and Griffith, 1992) . Whereas neuronal and endothelial cNOS produce NO transiently dur ing agonist-induced increases in intracellular cal cium, iNOS produces NO continuously (see Nathan, 1992) . Thus, transient NO production by cNOS has been implicated mainly in the signaling functions of NO, while sustained NO production by iNOS has been implicated in cytotoxicity (Nathan, 1992) .
The roles that the different isoforms of NOS play in cerebral ischemic damage have not been eluci dated. Data from other cell systems suggest that iNOS induction in the ischemic tissue would be det rimental to neuronal viability (Nathan, 1992) . How ever, it has not been established whether, after ce rebral ischemia, there is induction of iNOS within the affected tissue. In this study we therefore sought to determine whether iNOS activity is in creased in the ischemic brain. We found that sub stantial induction of iNOS activity occurs between 1 and 2 days after permanent focal ischemia in spon taneously hypertensive rats (SHR). In contrast to iNOS, cNOS activity is markedly reduced. The re sults raise the possibility that sustained NO produc tion by iNOS contributes to the late phase of cere bral ischemic damage.
METHODS
Methods for middle cerebral artery (MCA) occlusion, for determination of NOS activity, for NADPH diapho rase histochemistry, and for glial fibrillary acidic protein (GF AP) immunohistochemistry have been described in detail in previous publications (lade cola et aI., 1990 , 1994b Iadecola, 1993, 1994; F. Zhang et aI., 1994) and are only summarized here.
Occlusion of the MCA
Studies were conducted on 40 male SHRs (Harland) weighing 30�00 g. Animals were anesthetized with halothane (5% induction; 1-2% maintenance) and placed on a stereotaxic frame. A 3-to 4-mm hole was drilled at the level of the left foramen ovale to expose the left MCA (Zhang and Iadecola, 1993; F. Zhang et aI., 1994) . The MCA was elevated and cauterized proximal to the origin of the lenticulostriate arteries. Surgery usually lasted 2� 30 min. Rats were then returned to their cages and closely monitored until they recovered from anesthesia. Rats were killed 1, 2, 4, and 7 days later and their brains rap idly removed. The area of ischemic damage could be eas ily identified because it appeared discolored. A 4-mm thick coronal brain slice was cut at the level of the optic chiasm and the infarcted cortex was dissected using the corpus callosum as a ventral landmark. The medial bor der of the cortical infarct was identified visually. The cor tex below the rhinal fissure was not sampled. The homo topic region of the contralateral cortex was also dis sected. Samples were frozen in liquid nitrogen for later analysis.
NOS assay
NOS catalytic activity was measured using the assay of Bredt and Snyder (1989) . Brain samples were homoge nized in 20 mM HEPES containing 0.5 mM EGT A, 1 mM dithiothreitol, and 0.32 M sucrose at 23,000 rpm for 30 s (Polytron/PT3000; Brinkmann). The homogenate was then centrifuged at 20,000 g for 15 min and the superna tant was applied to Dowex AG50W-X8 columns (NA + form) to remove endogenous arginine. Enzyme activity was assayed in triplicate aliquots of cytosol (150 IJ.g pro tein). For determination of calcium-dependent activity (cNOS), samples were incubated for 45 min (37°C) with a buffer (pH 7.4) containing 20 mM HEPES, 0.5 mM EGTA, 1 mM dithiothreitol, 0.32 M sucrose, 0.5 mM Ca2+ (1 IJ.M free Ca2+), 200 IJ.M NADPH, 1 IJ.M L-argi nine, and 1 IJ.Ci/ml L-eH]arginine (Bredt and Snyder, 1989; Iadecola et aI., 1994b) . The reaction was stopped by adding 2 ml of ice-cold 20 mM HEPES containing 2 mM EDTA (pH 5.5). Samples were applied to Dowex AG50W-X8 (NA + form) columns to remove L-[3H]argi nine. Columns were then washed with 2 ml of water and L-[3H]citrulline was quantified in the flow-through frac tion using a liquid scintillation spectrophotometer (Beck man LS 6000). The level of L-[3H]citrulline was computed after subtracting the blank value, which represents non specific radioactivity in absence of enzyme.
For determination of calcium-independent NOS activ ity (iNOS), the incubation buffer also included the cofac tors tetrahydrobiopterin (THB; 50 IJ.M), FMN (1 IJ.M), and FAD (1 IJ.M) but was devoid of calcium (Szabo et aI., 1993) . In preliminary studies we observed that after lipo polysaccharide (LPS) treatment, no calcium-independent activity was observed in susceptible organs, despite re verse-transcriptase polymerase chain reaction (RT -PCR) verified iNOS mRNA induction, unless THB was added to the reaction mixture. FMN and FAD were found not to be as essential as THB. In contrast to calcium independent activity, calcium-dependent NOS activity could be measured in brain in the absence of these cofac tors (cf. Bredt and Snyder, 1989) . Therefore, in subse quent studies on postischemic brain we routinely added THB, FMN, and FAD only to the assay for calcium independent NOS. As a consequence, in the assay for calcium-dependent NOS the calcium-independent activ ity was not detected because THB was not present. Be cause of these differences in the assay conditions, cal cium-dependent and calcium-independent NOS activities cannot be directly compared. However, the comparisons of the different time points within each assay are valid.
RT-PCR analysis of iNOS
To validate the assay for iNOS, five rats were injected intraperitoneally with bacterial LPS (Klebsiella pneumo niae, 10 mg/kg; Sigma), a treatment that results in sub stantial iNOS induction in different organs (Knowles et al., 1990; Lowenstein et aI., 1992) . Six hours later, brain (cortex), spleen, and lung were removed and tissue sam ples for RT-PCR were collected. Tissue levels of mRNA in control and LPS-treated rats were assessed by reverse transcription followed by PCR amplification of cDNA as described elsewhere (Kawasaki et aI., 1988) . Total RNA was extracted by the method of Chomczynski and Sacchi (1987) and the integrity of the preparations was assessed on denaturing formaldehyde gels. In parallel, tissue.sam pIes from the same animals were used for enzymatic as say of iNOS activity for comparison. First-strand cDNA synthesis was carried out using 1 IJ.g of total RNA, oligo (dT) primer (BRL), and M-MuLV reverse transcriptase (New England BioLabs) according to manufacturer's in structions. Aliquots (5 IJ.I each) from the same RT reac tion for a given tissue were then used for PCR amplifica tion using primer pairs from the coding regions of either �-actin or iNOS (Lowenstein et al., 1992) . NOS primer sequences were selected for their ability to distinguish the inducible enzyme from the other published NOS iso forms. Amplified cDNA products were electrophoretical ly separated on a 1 % agarose gel and visualized by stain ing with ethidium bromide. RT-PCR reactions were ad justed so that the amount of RNA used (1 fLg each) was within the linear range of the assay (data not shown). That equivalent amounts of RNA were used in each reaction was confirmed by (a) the intensity of 28S and 18S ribo somal bands on denaturing RNA gels and (b) the amount of j3-actin as well as porphobilinogen deaminase RT-PCR products amplified as control.
NADPH-diaphorase histochemistry and

GF AP immunohistochemistry
In separate experiments (n = 2 per day), the MCA was occluded and 1, 2, 4, and 7 days later SHR were deeply anesthetized (pentobarbital, tOO mg/kg i.p.) and perfused through the heart with 4% paraformaldehyde. Sham operated rats (n = 2) served as controls. Brains were removed, and after postfixation and cryoprotection, co ronal brain sections (30 fLm) were cut in a cryostat at -20°C (Bright-Hacker). NADPH-diaphorase histochem istry or GFAP immunohistochemistry was performed as described previously (lade cola et aI., 1990, 1993) .
Data analysis
Data are expressed as means ± SD. Comparisons among multiple groups were statistically evaluated by the analysis of variance and the Tukey-Kramer modification of Tukey's test (Systat, Inc.).
RESULTS
Characterization of the assay for detection of iNOS activity
To validate assay conditions for iNOS we studied iNOS induction after intraperitoneal injection of LPS. As shown in Fig. lA , marked induction of iNOS mRNA was seen in LPS-treated spleen, lung, and cerebral cortex, though the message level at tained was substantially lower in brain than in lung or spleen (cf. Lowenstein et al., 1992) . Equivalent amounts of �-actin were amplified from all samples, verifying the standardization of conditions save for primer pair. Samples without RNA template or in the absence of RT produced no bands. The rank order of intensity of induction seen on ethidium stained agarose gels, assessed densitometrically, paralleled the rank order of induction of iNOS en zymatic activity in the same tissues, i.e., lung > spleen> brain (Fig. 1B) . The lack of substantial iNOS induction in brain after systemic LPS treat ment is in agreement with previous reports (Knowles et al., 1990; Lowenstein et al., 1992) and might sug gest that LPS, cytokines, and/or related products of inflammation do not penetrate the blood-brain bar rier. These findings demonstrate that the assay used in this study is adequate for detection of induction of calcium-independent NOS activity. Shown are PCR ampli fication products using primer pairs from the coding region of either iNOS or j3-actin. LPS treatment leads to expression of iNOS in lung, spleen, and, to a significantly lesser extent in brain. No iNOS expression is seen in untreated controls (Co). Equivalent amounts of j3-actin are amplified from all samples, verifying standardization of conditions. The intensity of iNOS expression was quantified from the gel using an image anal ysis system (M4; Imaging Research Inc.) (Uu et aI., 1993) . The products of the relative optical density times the area of the bands were 5.0, 85.7, and 119.0 for brain, spleen, and lungs, respectively. Therefore, the rank order of mRNA expression was lung> spleen> brain. BL, sample without RNA; Std, DNA standards. B : Effect of LPS on iNOS (calcium independent) activity in lung, spleen, and brain. Treatment with LPS leads to development of substantial iNOS activity in lung and spleen and, to a lesser extent, in brain. Note that the rank order of induction of enzymatic activity is identical to that of mRNA induction as established by RT-PCR (lung> spleen> brain). iNOS activity in rats not treated with LPS was 219 ± 172,125 ± 74, and 141 ± 93 (dpm/150 fL9 protein/ 45 min) for lung, spleen, and brain, respectively (p > 0.05 from blank).
NOS and iNOS activity in the area of infarction
The time course of calcium-dependent (cNOS) and calcium-independent (iN OS) activity in the cor tical infarct is illustrated in Fig. 2 . cNOS activity was dramatically reduced at 24 h after the induction of ischemia (p < 0.00 1 from sham; analysis of vari ance and Tukey's test) and remained attenuated up to 7 days after MCA occlusion (p < 0.001). cNOS activity did not change significantly in the neocor tex contralateral to the stroke (p > 0.05). In sham operated rats, iNOS activity was not significantly different from blank (p > 0.05), a finding reflecting a lack of iNOS expression in the normal brain (cf. Fig. 1A) . After MCA occlusion, no induction of iNOS activity was seen in the infarcted neocortex at 1 day (p > 0.05). However, marked iNOS induction was observed at days 2 and 4 (p < 0.005). Seven days after MCA occlusion iNOS activity was not different from blank (p > 0.05). No induction of iNOS activity was observed in the cerebral cortex contralateral to MCA occlusion (p > 0.05). As shown in Fig. 3 , the calcium-independent NOS activity of ischemic brains 48 h after MCA occlusion was inhibited by monomethyl-L-arginine (L-NMMA) in a dose-dependent fashion (0. 1-1,000 I-LM). The relationship between L-NMMA concen tration and degree of inhibition observed in the postischemic brain was virtually identical to that observed in homogenates of lungs of animals treated with LPS.
NADPH-diaphorase-positive neurons and
GFAP-positive astrocytes within the lesion
One day after MCA occlusion no NADPH diaphorase-positive neurons were observed within the infarct core. However, residual NADPH di aphorase neurons were seen in the superior border zone of the infarct. Increased NADPH diaphorase activity was noticed in vascular cells at days 2 and 4 ( Fig. 4) . Macrophages were observed starting at day 2 and became more marked at days 4 and 7. "At day 7, GF AP-positive astrocytes surrounded areas of necrosis and macrophage infiltration (Fig. 4) .
DISCUSSION
We have demonstrated that after MCA occlusion there is development of substantial calcium independent (iN OS) activity in the affected neocor- tex. This enzymatic activity peaks at 2 days and returns to baseline by 7 days after induction of isch emia. The neocortical iNOS activity after ischemia is greater than that observed in brain after systemic administration of LPS. In contrast to iNOS, neo cortical eNOS activity is markedly reduced after MCA occlusion. These observations indicate that after cerebral ischemia there is a marked reduction in eNOS and a substantial induction of iNOS within the area of the infarct.
The increase in iNOS catalytic activity cannot be an artifact of the enzymatic assay used. First, we have validated the sensitivity of the assay by study ing iNOS induction in LPS-injected rats. We found that iNOS activity in various organs corresponds well to the intensity of induction of iN OS mRNA, established by RT-PCR. Second, L-NMMA, a po tent iNOS inhibitor (Gross et aI., 1990) , inhibited the calcium-independent NOS catalytic activity of the postischemic brain with a pattern similar to that of lungs of LPS-treated rats. The similarity of the pattern of inhibition supports the conclusion that iNOS is responsible for the calcium-dependent NOS activity in the postischemic brain. Third, the fact that the calcium-independent NOS activity was induced markedly, whereas the calcium-dependent NOS activity was nearly abolished, attests to the specificity of the assay in discriminating between inducible and constitutive isoforms. These observa tions strongly suggest that the calcium-independent conversion of arginine to citrulline observed after MCA occlusion reflects induction of iNOS in the area of the infarct.
Histopathological analysis revealed loss of NADPH diaphorase-containing neurons in the area of the infarct by day 1. Macrophages were seen by day 2 and were very abundant at day 7, whereas GF AP-positive astrocytes were most evident at day 7. These morphological observations indicate that the reduction in eNOS activity in the area of infarc tion reflects loss of NOS-containing neurons and that the induction of iNOS activity is linked to the presence of nonneuronal cells. However, the time course of iNOS induction does not closely parallel the time course of accumulation of nonneuronal cells and astrocytic activation: iNOS activity starts to decline at 7 days, a time when cellular infiltration and GFAP expression are maximal. Therefore, iNOS induction does not merely reflect accumula tion of nonneuronal cells within the lesion.
After focal cerebral ischemia, iNOS activity could be induced in endothelial and smooth muscle cells, as well as in astrocytes, microglia, macro phages, and leukocytes (for a review see Nathan, 1992) . However, the cellular origin of iNOS activity cannot be determined on the basis of the present study because enzyme activity was assayed in the whole infarct. Although, activated glial cells, leuko cytes, and macrophages in the lesion could be a source of iN OS, we did not establish whether iN OS immunoreactivity or NADPH diaphorase activity is expressed in these cells. Of interest is the possibil ity that iNOS is induced also in endothelial and smooth muscle cells (Gross et aI., 199 1; MacNaul and Hutchinson, 1993) . The enhanced NADPH di aphorase activity in vascular cells observed at day 4 would support this hypothesis. However, the in creased vascular NADPH diaphorase activity could also reflect up regulation of endothelial eNOS, a phenomenon that has been reported after focal ce rebral ischemia (Z. G. Zhang et aI., 1993) . Further studies will be required to determine the cellular sites of iNOS induction.
In the present study we have provided evidence that iNOS is induced after focal cerebral ischemia. At variance with eNOS, iNOS is regulated by DNA transcription, and once the enzyme has been syn thesized, it produces NO continuously for as long as it is functional (for a discussion see Nathan, 1992) . Sustained and continuous production of NO can be detrimental to the ischemic tissue. Mecha nisms of NO-induced cytotoxicity include inhibition of the glycolytic enzyme glyceraldehyde-3-phos phate dehydrogenase (e.g., Dimmeler et aI., 1992) and of the mitochondrial enzymes aconitase and complexes I and II (see Nathan, 1992) . In addition, NO produces DNA damage, inhibits DNA replica tion, and activates poly(adenosine 5' -diphosphori bose) synthetase, an enzyme that may lead to neu rotoxicity by depletion of essential substrates and ATP (Nathan, 1992; 1. Zhang et aI., 1994) . NO can also be toxic by formation of peroxynitrite (Beck man et aI., 1990) .
The finding that iNOS catalytic activity after stroke is lower than eNOS catalytic activity in the normal brain should not be interpreted to indicate that the normal brain is exposed to more NO than the infarcted tissue. eNOS catalytic activity, as de termined ex vivo by the citrulline assay, reflects maximal enzyme activity in the constant presence of calcium. In the normal brain, in vivo, eNOS is activated phasically during transient increases in in tracellular calcium and produces pulses of NO in termittently (Garthwaite, 199 1; Stuehr and Griffith, 1992) . As discussed above, iNOS produces NO continuously. Therefore, sustained NO production by iNOS is likely to have deleterious effects on the ischemic brain.
Because iNOS activity peaks between 1 and 2 days after MCA occlusion, NO production cannot be responsible for the brain damage that occurs within hours after ischemia. It is therefore conceiv able that, if NO produced by iNOS is detrimental to the tissue, it must contribute to the late phases of ischemic damage. Although the tissue damage in the core of the infarct develops fully within 6--8 h of ischemia, the areas surrounding the ischemic core remain viable for days (Dereski et aI., 1993; Garcia et aI., 1993) . In these regions reversal of neuronal damage occurs even 3 days after MCA occlusion (Dereski et aI., 1993) . Therefore, NO produced by iNOS between 1 and 4 days after ischemia may, in part, determine whether the tissue surrounding the ischemic core undergoes infarction. Hence, inhibi tion of iNOS at this time may have therapeutic po tential. Studies are currently in progress to address this issue.
Data from this and other laboratories suggest that the effects of NO on cerebral ischemic damage are time dependent. In the early phases of cerebral ischemia the vasodilator action of NO is beneficial to the tissue, as it contributes to maintain blood flow in oligemic areas at risk for infarction. Indeed, administration of NO donors within 60 min after permanent MCA occlusion improves blood flow and reduces infarction Iadecola, 1993, 1994; F. Zhang et aI., 1994) . After 2 h of ischemia, NO donors do not affect blood flow and do not reduce ischemic infarction (Zhang and Iadecola, 1994) , indicating that the vascular effects of NO are no longer beneficial. In the later stages of ischemic damage, however, the toxic effects of NO can be detrimental to the ischemic tissue. Our finding that iNOS is induced within the area of the lesion be tween 1 and 2 days after stroke supports the hy pothesis that sustained NO production by iNOS contributes to tissue damage. However, the molec ular mechanisms of iNOS expression and the cellu lar site(s) of enzyme induction remain to be deter mined.
In conclusion, we have demonstrated that iNOS activity is induced in the area of infarction after permanent MCA occlusion in SHRs. iNOS activity is turned on between 1 and 2 days after induction of ischemia, at a time when cellular infiltration of the infarct by nonneuronal cells is detected. The find ings support the hypothesis that sustained produc tion of NO by iNOS in nonneuronal cells contrib utes to the expansion of the infarct that occurs in the late phase of focal cerebral ischemia.
